April 8, 2022: Article in French - MaaT Pharma launches its Phase 2a clinical trial in melanoma - MaaT Pharma

To read the article, click here

Previous PostApril 8, 2022: Interview of Hervé Affagard in Boursier in French
Next PostMaaT Pharma Announces the Initiation of a Phase 2a Investigator-Sponsored Clinical Trial Evaluating MaaT013 in Combination with Immune Checkpoint Inhibitors for Patients with Melanoma

© 2025 MaaT Pharma. MaaT Pharma’s mission is to restore microbiome function to treat life-threatening diseases

MaaT Pharma dans les médias MaaT Pharma in the News Devenez membre du club Become a member of the club